Condition: Short Bowel Syndrome (SBS) in Adults · Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
This is a multicenter, open-label, single-arm clinical trial. A total of 100 participants with short bowel syndrome (SBS) receiving parenteral nutrition (PN) support are planned to be enrolled. The trial includes a 2-week run-in phase and a 4-week intervention phase, during which participants will receive rhGH injections. A safety follow-up period will then be conducted through Week 52.
This description comes directly from the study's public registry record.
Feifei Liu · +86 13156199093 · liufeifei@genscigroup.com
Always discuss trial participation with your own doctor first.
| Zhongshan Hospital Affiliated to Xiamen University | Xiamen, Fujian, China | Recruiting |
| General Hospital of Eastern Theater Command | Nanjing, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07691125